Low Doses of Psilocybin and Ketamine Enhance Motivation and Attention in Poor Performing Rats: Evidence for an Antidepressant Property

• Main Authors: Guy A. Higgins (Author), Nicole K. Carroll (Author), Matt Brown (Author), Cam MacMillan (Author), Leo B. Silenieks (Author), Sandy Thevarkunnel (Author), Julia Izhakova (Author), Lilia Magomedova (Author), Ines DeLannoy (Author), Edward M. Sellers (Author)
• Format: Book
• Published: Frontiers Media S.A., 2021-02-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Long term benefits following short-term administration of high psychedelic doses of serotonergic and dissociative hallucinogens, typified by psilocybin and ketamine respectively, support their potential as treatments for psychiatric conditions such as major depressive disorder. The high psychedelic...